Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3012774 | 1.00 | LAP3 (0.32) | LAP3MMP1MMP2MMP3MEN1 | |
| SCHEMBL8412621 | 0.84 | ANPEP (0.37) | LAP3MEN1LMNAHPGDTSHR | |
| SCHEMBL8414243 | 0.84 | ANPEP (0.37) | LAP3MEN1LMNAHPGDTSHR | |
| SCHEMBL8411160 | 0.84 | LAP3 (0.33) | LAP3MEN1LMNAHPGDTSHR | |
| SCHEMBL8412619 | 0.81 | — | — | |
| SCHEMBL8414236 | 0.81 | — | — | |
| SCHEMBL8413370 | 0.80 | MEN1 (0.32) | LAP3MEN1LMNAHPGDTSHR | |
| SCHEMBL8410804 | 0.74 | MEN1 (0.30) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL8822878 | 0.73 | FDPS (0.40) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL8630560 | 0.73 | GRIN2D (0.33) | LAP3MEN1LMNAHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5739161-A | PROSTAGLANDINS; DIARRHEA SIDE EFFECT REDUCTION | R-TECH UENO, LTD. (JP) | 1998-04-14 | — | — | US | disclosed |